Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)
ID: RFA-DA-24-017Type: BOTH
Overview

Topic

Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R41/R42 Clinical Trial Optional)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: STTRPhase: BOTHYear: 2023

Topic Link

https://www.sbir.gov/node/2398565

Additional Information

https://grants.nih.gov/grants/guide/RFA-files/RFA-DA-24-017.html
Timeline
  1. 1
    Release May 24, 2023 12:00 AM
  2. 2
    Open Oct 9, 2023 12:00 AM
  3. 3
    Next Submission Due Nov 9, 2023 12:00 AM
  4. 4
    Close Nov 10, 2023 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for a research topic focused on "Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment."

The goal of this solicitation is to develop field-deployable, low-cost approaches and technologies that can potentially reduce the barriers to diagnosis and treatment of substance use disorders. The aim is to bring treatment to the patient, rather than requiring the patient to travel for treatment.

The solicitation encourages proposals in several areas, including low-cost approaches to diagnosis and treatment suitable for low-resource settings, devices for mobile quantification of drugs and their metabolites during treatment, universal autoinjectors for accurate dosing of various therapeutics, and point-of-care approaches for dispensing liquid drugs with built-in security features.

The solicitation also emphasizes the need for solutions tailored to increase access to treatment in correctional facilities, poor and rural communities, and tribal areas, taking into account logistical, economic, and security constraints.

The Small Business Technology Transfer (STTR) program is a phased program, with Phase I focused on establishing technical merit and feasibility, and Phase II aimed at advancing the technology toward commercialization. Fast-Track applications, which include both Phase I and Phase II, are also accepted.

First-time applicants are welcome to submit Phase I or Fast-Track applications.

The deadline for proposal submission is November 10, 2023. More information can be found on the grants.gov website or the National Institutes of Health's solicitation agency URL.

Files
No associated files provided.
Similar Opportunities
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and/or stimulants use disorders (OUD/StUD). The current drug crisis surrounding OUD/StUD is a significant issue, with over 100,000 overdose deaths reported in a one-year period. The goal of this solicitation is to offer new medical products that can monitor, diagnose, and treat patients suffering from these disorders. The solicitation is open to small business companies that have developed or are developing FDA-regulated products for different indications and are interested in demonstrating their potential application in the OUD/StUD space. The research and development activities may fall into two areas: pharmacotherapeutics (small molecules and biologics) and medical therapeutic and diagnostic devices, including software as a medical device. The proposed projects should aim to address the needs of patients suffering from OUD/StUD and may include activities such as target identification, lead optimization, preclinical studies, formulation development, and clinical trials. The funding for these projects will be provided through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding available. The application due dates are August 15, 2023, February 14, 2024, August 13, 2024, and February 14, 2025. For more information and to apply, interested parties can visit the grants.gov website or the solicitation agency URL provided.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Fast-Track (Phase I/Phase II) applications, with a focus on establishing technical feasibility and commercial potential. The application due date is March 13th, 2024, with subsequent due dates in 2025 and 2026. More information can be found on the grants.gov website.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Phase II applications, including Fast-Track applications that combine both phases. The deadline for submission is March 14, 2026. For more information, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-047.html).
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and/or stimulants use disorders (OUD/StUD). The current drug crisis involving opioids and stimulants has resulted in a significant number of deaths and a need for comprehensive solutions. This funding opportunity aims to support research and development activities for novel medical products that address the needs of patients suffering from OUD/StUD. The two areas of focus are pharmacotherapeutics (small molecules, biologics, natural products, etc.) and medical therapeutic and diagnostic devices (imaging technologies, therapeutic devices, diagnostic assays, etc.). The projects proposed should aim to establish technical feasibility, commercial potential, and the quality of performance of the small business awardee organization. The funding opportunity includes Phase I, Phase II, Fast Track, and Direct to Phase II applications. The deadline for applications is February 15, 2025. For more information and to apply, visit the grants.gov website or the solicitation agency URL provided.
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Phase II applications, including Fast-Track applications. The application due date is March 13th of each year, starting in 2024. For more information, visit the [solicitation link](https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-048.html).